Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda

INTRODUCTION: Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI) mutations (VF-M) is on the rise. However, there is a paucity of information on the factors associated with this observation in low-income countries. Knowledge of underlying factors is critical if we are to...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AIDS Res Ther
Auteurs principaux: Musana, Hellen, Ssensamba, Jude Thaddeus, Nakafeero, Mary, Mugerwa, Henry, Kiweewa, Flavia Matovu, Serwadda, David, Ssali, Francis
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059285/
https://ncbi.nlm.nih.gov/pubmed/33882938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12981-021-00338-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires